The core domain of hepatitis C virus glycoprotein E2 generates potent cross‐neutralizing antibodies in guinea pigs

A vaccine that prevents hepatitis C virus (HCV) infection is urgently needed to support an emerging global elimination program. However, vaccine development has been confounded because of HCV's high degree of antigenic variability and the preferential induction of type‐specific immune responses...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Hepatology
Huvudupphovsmän: Vietheer, Patricia T., Boo, Irene, Gu, Jun, McCaffrey, Kathleen, Edwards, Stirling, Owczarek, Catherine, Hardy, Matthew P., Fabri, Louis, Center, Rob J., Poumbourios, Pantelis, Drummer, Heidi E.
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley and Sons Inc. 2017
Ämnen:
Viral Hepatitis
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5408392/
https://ncbi.nlm.nih.gov/pubmed/27997681
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.28989
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk